Literature DB >> 32436932

miRactDB characterizes miRNA-gene relation switch between normal and cancer tissues across pan-cancer.

Hua Tan, Pora Kim, Peiqing Sun, Xiaobo Zhou.   

Abstract

It has been increasingly accepted that microRNA (miRNA) can both activate and suppress gene expression, directly or indirectly, under particular circumstances. Yet, a systematic study on the switch in their interaction pattern between activation and suppression and between normal and cancer conditions based on multi-omics evidences is not available. We built miRactDB, a database for miRNA-gene interaction, at https://ccsm.uth.edu/miRactDB, to provide a versatile resource and platform for annotation and interpretation of miRNA-gene relations. We conducted a comprehensive investigation on miRNA-gene interactions and their biological implications across tissue types in both tumour and normal conditions, based on TCGA, CCLE and GTEx databases. We particularly explored the genetic and epigenetic mechanisms potentially contributing to the positive correlation, including identification of miRNA binding sites in the gene coding sequence (CDS) and promoter regions of partner genes. Integrative analysis based on this resource revealed that top-ranked genes derived from TCGA tumour and adjacent normal samples share an overwhelming part of biological processes, which are quite different than those from CCLE and GTEx. The most active miRNAs predicted to target CDS and promoter regions are largely overlapped. These findings corroborate that adjacent normal tissues might have undergone significant molecular transformations towards oncogenesis before phenotypic and histological change; and there probably exists a small yet critical set of miRNAs that profoundly influence various cancer hallmark processes. miRactDB provides a unique resource for the cancer and genomics communities to screen, prioritize and rationalize their candidates of miRNA-gene interactions, in both normal and cancer scenarios.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  correlation; epigenetic regulation; genetic mechanism; microRNA activation; pan-cancer

Mesh:

Substances:

Year:  2021        PMID: 32436932      PMCID: PMC8138827          DOI: 10.1093/bib/bbaa089

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   11.622


  45 in total

1.  Oncogenic role of miR-483-3p at the IGF2/483 locus.

Authors:  Angelo Veronese; Laura Lupini; Jessica Consiglio; Rosa Visone; Manuela Ferracin; Francesca Fornari; Nicola Zanesi; Hansjuerg Alder; Gemma D'Elia; Laura Gramantieri; Luigi Bolondi; Giovanni Lanza; Patrizia Querzoli; Adriano Angioni; Carlo M Croce; Massimo Negrini
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

2.  Combinatorial Targeting by MicroRNAs Co-ordinates Post-transcriptional Control of EMT.

Authors:  Joseph Cursons; Katherine A Pillman; Kaitlin G Scheer; Philip A Gregory; Momeneh Foroutan; Soroor Hediyeh-Zadeh; John Toubia; Edmund J Crampin; Gregory J Goodall; Cameron P Bracken; Melissa J Davis
Journal:  Cell Syst       Date:  2018-07-11       Impact factor: 10.304

3.  Selective inhibition of tumor oncogenes by disruption of super-enhancers.

Authors:  Jakob Lovén; Heather A Hoke; Charles Y Lin; Ashley Lau; David A Orlando; Christopher R Vakoc; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

Review 4.  Cancer genome landscapes.

Authors:  Bert Vogelstein; Nickolas Papadopoulos; Victor E Velculescu; Shibin Zhou; Luis A Diaz; Kenneth W Kinzler
Journal:  Science       Date:  2013-03-29       Impact factor: 47.728

5.  HMDD v3.0: a database for experimentally supported human microRNA-disease associations.

Authors:  Zhou Huang; Jiangcheng Shi; Yuanxu Gao; Chunmei Cui; Shan Zhang; Jianwei Li; Yuan Zhou; Qinghua Cui
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

6.  GenBank.

Authors:  Dennis A Benson; Ilene Karsch-Mizrachi; David J Lipman; James Ostell; David L Wheeler
Journal:  Nucleic Acids Res       Date:  2005-01-01       Impact factor: 16.971

7.  miRDB: an online resource for microRNA target prediction and functional annotations.

Authors:  Nathan Wong; Xiaowei Wang
Journal:  Nucleic Acids Res       Date:  2014-11-05       Impact factor: 16.971

8.  KEGG: new perspectives on genomes, pathways, diseases and drugs.

Authors:  Minoru Kanehisa; Miho Furumichi; Mao Tanabe; Yoko Sato; Kanae Morishima
Journal:  Nucleic Acids Res       Date:  2016-11-28       Impact factor: 16.971

9.  An integrated encyclopedia of DNA elements in the human genome.

Authors: 
Journal:  Nature       Date:  2012-09-06       Impact factor: 49.962

10.  The IGF2 intronic miR-483 selectively enhances transcription from IGF2 fetal promoters and enhances tumorigenesis.

Authors:  Mingzhu Liu; Anna Roth; Min Yu; Robert Morris; Francesca Bersani; Miguel N Rivera; Jun Lu; Toshihiro Shioda; Shobha Vasudevan; Sridhar Ramaswamy; Shyamala Maheswaran; Sven Diederichs; Daniel A Haber
Journal:  Genes Dev       Date:  2013-12-01       Impact factor: 11.361

View more
  4 in total

1.  Down-Regulation of miR-194-5p for Predicting Metastasis in Breast Cancer Cells.

Authors:  Yu-Ting Yen; Jou-Chun Yang; Jiun-Bo Chang; Shih-Chang Tsai
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

2.  The clinical value of miRNA-21 in cervical cancer: A comprehensive investigation based on microarray datasets.

Authors:  Zhi-Min Deng; Gan-Hong Chen; Fang-Fang Dai; Shi-Yi Liu; Dong-Yong Yang; An-Yu Bao; Yan-Xiang Cheng
Journal:  PLoS One       Date:  2022-04-29       Impact factor: 3.240

3.  miR-21-5p/PRKCE axis implicated in immune infiltration and poor prognosis of kidney renal clear cell carcinoma.

Authors:  Jinxiang Wang; Jie Jin; Yanling Liang; Yihe Zhang; Nisha Wu; Mingming Fan; Fangyin Zeng; Fan Deng
Journal:  Front Genet       Date:  2022-09-13       Impact factor: 4.772

4.  Somatic mutation in noncoding regions: The sound of silence.

Authors:  Hua Tan
Journal:  EBioMedicine       Date:  2020-10-20       Impact factor: 8.143

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.